Schott launches InJentle syringe to improve drug stability

By Nick Taylor

- Last updated on GMT

Related tags: Pharmaceutical drug, Pharmacology

Schott AG has launched its InJentle syringe to improve the stability of highly sensitive drugs, which is a “major topic” for the company’s clients, according to a company director.

Speaking to in-PharmaTechnologist at Pharmapack 2010, Gregor Dudek, director, product management pharmaceutical packaging at Schott, explained that the syringe is designed to prevent the drug coming into contact with potential contaminants.

The syringe also has a tamper-evident closure and can be modified to include additional anti-counterfeiting features, such as radiofrequency identification (RFID) tags.

Additionally, sharper ‘virgin’ needles are used to make the injection less painful for patients. Particularly thin, siliconised needles can also be used to improve patient application.

Related news

Show more

Related products

From Candidate to Clinic- European Capabilities

From Candidate to Clinic- European Capabilities

Catalent Pharma Solutions | 22-Oct-2018 | Technical / White Paper

Catalent’s Nottingham, UK facility focuses on early stage development of small molecule drug candidates from the bench to clinic. This facility offers...

Fill Release at the Right Time in the Right Place

Fill Release at the Right Time in the Right Place

Gelita AG | 19-Sep-2018 | Technical / White Paper

From rapid release in the stomach for e.g. analgesics to enteric release for fills with unpleasant aftertaste – GELITA delivers the respective gelatine...

Strategies to Select and Deliver the Right Candidate

Strategies to Select and Deliver the Right Candidate

Catalent Pharma Solutions | 05-Mar-2018 | Technical / White Paper

Does your candidate have what it takes to succeed? Do you have the information needed to make the right decisions about your candidate’s path to the clinic?...

Related suppliers

Follow us

Products

View more